Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_provenance.
- NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_assertion description "[Eligible patients were older than 18 years of age; had histologically or cytologically confirmed stage IIIB-IV KRAS-mutant NSCLC; had failed first-line therapy for advanced NSCLC; had WHO performance status of 0-1; had not received previous therapy with either a MEK inhibitor or docetaxel; and had adequate bone marrow, renal, and liver function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_provenance.
- NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_assertion evidence source_evidence_literature NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_provenance.
- NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_assertion SIO_000772 23200175 NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_provenance.
- NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_assertion wasDerivedFrom befree-20150227 NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_provenance.
- NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_assertion wasGeneratedBy ECO_0000203 NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_provenance.
- befree-20150227 importedOn "2015-02-27" NP646189.RAYh8X58YTDGIOwWQlQUEyuQc05b8QqK-F-cs1fo9M_1Q130_provenance.